A carregar...
Immunotherapy: Who is Eligible?
Recurrent and/or metastatic head and neck cancer portends a poor prognosis with traditional treatments, but current immunotherapy with immune checkpoint inhibitors has the potential to improve these clinical outcomes. This review focuses on the major breakthroughs that have led to our current unders...
Na minha lista:
| Publicado no: | Otolaryngol Clin North Am |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282181/ https://ncbi.nlm.nih.gov/pubmed/28755708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.otc.2017.04.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|